ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$2.01
-0.07 (-3.37%)
As of Jun 30, 10:24 PM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 8 57%
Hold 4 29%
Sell 2 14%
Price Target
Analyst Price Target +959.7% upside
Low Target $14.71
Average Target $21.30
High Target $34.17
Current Price $2.01
Current
$2.01
Target
$21.30
$14.71 $21.30 avg $34.17
Scenario Analysis
Bear Case
$14.71
631.8%
Low target
Base Case
$21.30
+959.7%
Avg target
Bull Case
$34.17
+1,600.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$3.40
-40.9% from high
52-Week Low
$1.09
+84.4% from low
Target vs 52W High
$21.30
+526.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%